Related by context. All words. (Click for frequent words.) 64 Six3 64 GATA3 63 beta1 integrin 62 KRAS oncogene 62 prognostic marker 61 inhibit metastasis 61 oncogenesis 61 ADAMTS# 61 diagnostic biomarker 61 Pim kinases 61 Alpha synuclein 61 molecular subtypes 61 Dr. Pestell 61 precursor lesions 61 TLE3 60 IDH mutations 60 pancreatic colon 60 antibody mediated 60 deCODE ProstateCancer TM 60 Lymph node 60 HER2 neu 60 prognostic indicator 60 Src kinase 60 clonogenic 60 cathepsins 59 tumor suppressor protein 59 PKCi 59 ADAM# 59 precancerous tissues 59 radiolabeled TM# 59 autoimmune pancreatitis 59 chemo resistant 59 Wnt signaling pathway 59 MAPK pathway 59 molecular abnormalities 59 Chronic pancreatitis 59 pancreatic lung 59 BRCA deficient 59 PCA3 gene 59 TGF alpha 59 metastatic lymph nodes 59 Corus CAD 59 Colon polyps 59 â catenin 59 Adjuvant therapy 59 prognostic markers 59 Smad3 58 cellular immunotherapy 58 Epigenomics proprietary 58 c myc gene 58 Wnts 58 immunodeficiency disorders 58 autoantigen 58 stratifying patients 58 biologic pathways 58 hedgehog signaling 58 FGFR3 58 colorectal carcinoma 58 methylation markers 58 nodal metastasis 58 recurrent ovarian 58 p# pathway 58 pre malignant lesions 58 androgen dependent 58 HIF 1α 58 FGFR2 gene 58 PEDF 58 angiogenesis inhibition 58 hypermethylated 58 kidney urologic 58 antimetastatic 58 metastatic bladder 58 hormonally sensitive 58 squamous cell lung cancer 58 anti angiogenic therapy 58 DNA methylation biomarker 58 gastrointestinal stromal tumors GISTs 57 pathogenic mechanisms 57 podocyte 57 epithelial barrier 57 deCODE BreastCancer 57 TMPRSS2 ERG fusion 57 CaM kinase II 57 TMEM density 57 Surgical resection 57 hormone receptor negative 57 chemoresistance 57 malignant phenotype 57 druggable targets 57 CXCR7 57 galectin 57 hedgehog signaling pathway 57 Prox1 57 uPA 57 Medullary thyroid cancer 57 HER signaling pathway 57 focal adhesion kinase FAK 57 tumorigenesis 57 MAP kinase 57 ZNF# 57 malignant transformation 57 mTOR inhibition 57 Shark cartilage 57 PARP inhibition 57 leukocyte recruitment 57 A3 adenosine receptor 57 cervical breast 57 Ii protein 57 viral pathogenesis 57 Akt3 57 drug GAP #B# 57 serous ovarian cancer 57 molecular biomarkers 57 tissue fibrosis 57 PDGF receptor 57 galectin 3 57 pathological hallmark 57 lymphangiogenesis 57 genetic biomarkers 57 pancreatic adenocarcinoma 57 recurrent metastatic 57 oncoprotein 57 carcinoids 57 epigenomics 56 breast endometrial 56 adipogenesis 56 K ras mutation 56 SGLT2 inhibitors 56 fibrin deposition 56 neoplastic transformation 56 prostate carcinomas 56 Hh pathway 56 chromosomal translocation 56 p# biomarker 56 metabolomic profiles 56 PKM2 56 epigenetic regulation 56 VE cadherin 56 DNA methylation patterns 56 SCD1 56 apoptotic pathway 56 leukemias lymphomas 56 genetic loci 56 lymphatic vasculature 56 underlying molecular mechanisms 56 genomewide association studies 56 epithelial tumors 56 cell signaling pathways 56 GSK3 56 cervical uterine 56 ReN# 56 Nod1 56 MUC1 * 56 hedgehog pathway 56 Molecular imaging 56 PRESEPT study 56 CBLC# 56 CD# ligand 56 MEF2A 56 Ets2 56 peritoneal carcinomatosis 56 abnormal glucose metabolism 56 posttranslational modifications 56 renal fibrosis 56 pancreatic endocrine 56 molecular determinants 56 non resectable metastatic 56 KRAS mutated 56 prostate carcinoma 56 ascites fluid 56 FSH receptor 56 CXCR4 receptor 56 colorectal gastric 56 KRAS mutation 56 MiCK assay 56 pathogenetic 56 tumor metastasis 56 proto oncogene 56 ANGPTL4 56 AML acute myeloid 56 mutated p# 56 genomic instability 56 SERCA2a 56 somatostatin receptors 56 C. pneumoniae 56 Genetic predisposition 56 monogenic 56 HAAH 56 gene rearrangements 56 ERBB4 56 biomarker identification 56 underlying pathophysiology 56 benign moles 56 prostate carcinogenesis 55 Seewaldt 55 sphingolipid 55 neoplastic diseases 55 p# Shc 55 pituitary adenomas 55 unresectable tumors 55 epithelial tissues 55 ovarian pancreatic 55 lung metastasis 55 pre mRNA splicing 55 genetic locus 55 fibrogenesis 55 causative genes 55 n cofilin 55 endometrial breast 55 metastatic colorectal 55 primary hyperparathyroidism 55 coagulation cascade 55 JAK#/JAK# 55 HER2 amplified 55 prognostic biomarkers 55 haematopoietic 55 polyps growths 55 IRF6 55 hereditary predisposition 55 mutated K ras 55 pharmacological chaperone 55 TRAIL induced apoptosis 55 miRview mets 55 transgenic mouse model 55 membranous nephropathy 55 metastatic gastric 55 C5aR 55 murine model 55 carcinoembryonic antigen 55 acinar 55 treating peripheral arterial 55 organogenesis 55 breast pancreatic 55 HER2 positive breast 55 intracellular bacteria 55 pancreatic ductal 55 cells multiply uncontrollably 55 EGF receptor 55 MitoQ 55 PITX2 55 mammary duct 55 mutated BRAF gene 55 ovarian endometrial 55 Hedgehog signaling 55 interleukin 1beta 55 NR#A# 55 Preimplantation Factor 55 tenascin C 55 C EBP alpha 55 motor neuron degeneration 55 extramedullary 55 lung fibrosis 55 microRNA expression 55 HDAC6 55 Singh Manoux 55 epithelial cancers 55 myogenesis 55 Notch signaling pathway 55 VEGF expression 55 clotting cascade 55 DNA methylation markers 55 beta islets 55 GPC5 55 clinicopathological 55 GPx 55 cervical prostate 55 cisplatin resistant 55 Avastin Tarceva 55 leukocyte adhesion 55 percutaneous biopsy 55 heterologous 55 SSc 55 therapeutic monoclonal antibody 55 EGFR pathway 55 benign polyps 55 druggable target 55 humanised antibody 55 TGF ß 55 K ras mutations 55 cervical lymph node 55 prognostic indicators 55 chemoresistant 55 mRNA decay 55 Metastatic colorectal cancer 55 mTOR signaling pathway 55 GATA4 55 Dr. Dadachova 55 NSCLC tumors 55 immunohistochemical staining 54 epigenetic modification 54 obstructive coronary artery 54 eIF 4E 54 Pervasis 54 oncomodulin 54 cell signaling pathway 54 breast uterine 54 carcinoma HCC 54 FOXM1 54 HCV replication 54 microRNA miR 54 alpha synuclein gene 54 sickle cell hemoglobin 54 granulosa cell 54 COX enzymes 54 gastric carcinoma 54 antisense RNA 54 esophageal gastric 54 Galectin 3 54 miR #a [002] 54 somatic mutations 54 TroVax ® 54 ovarian breast 54 immunohistochemical 54 Prof. Krainer 54 chromosome condensation 54 pulmonary metastasis 54 BRAF V#E mutation 54 β catenin 54 primary cilia 54 spontaneous regression 54 triterpenoids 54 cAMP signaling 54 Apobec3 54 Myc gene 54 atherosclerosis regression 54 diabetic cardiomyopathy 54 Her2 positive 54 airway remodeling 54 inhibit viral replication 54 CDK inhibitors 54 IL 7R 54 activated microglia 54 neoplastic 54 biliary tree 54 novel immunotherapeutic 54 hematopoiesis 54 multimodality therapy 54 intercellular signaling 54 arterial calcification 54 GVAX Pancreas Vaccine 54 sDNA 54 myopathies 54 non coding RNA 54 sortilin 54 node metastasis 54 immunotherapeutic approaches 54 Aquinox 54 neural crest 54 phenotypic expression 54 oncogenic signaling 54 anticancer therapeutics 54 ErbB2 positive 54 BrachySil TM 54 PhG alpha 1 54 lymphatic mapping 54 hormone receptor status 54 apoE 54 urothelial cancer 54 pancreatic prostate 54 FGF signaling 54 plasminogen activators 54 HuLuc# 54 liver metastasis 54 colorectal adenoma 54 chemosensitivity 54 Karlseder 54 skeletal metastases 54 Wnt signaling 54 bladder ovarian 54 refractory metastatic 54 isoform selective 54 small molecule activators 54 Elevated PSA 54 promoter hypermethylation 54 Dr. Zimmerberg 54 metastatic pancreatic 54 ErbB3 receptor 54 cardiomyocyte 54 amyloid deposition 54 aerodigestive tract 54 Helicobacter 54 SIRT1 gene 54 EML4 ALK 54 chromosome #p#.# 54 thymosin beta 4 54 lymphoid organs 54 pain palliation 54 OnDose TM 54 malignant prostate 54 breast cancer metastasis 54 MMP2 gene 54 multiplex assay 54 Wnt beta catenin 54 Genetic variants 54 Lpathomab 54 ductal carcinomas 54 MIF gene 54 Tr DNA 54 prognostic factor 54 Surgical excision 54 E1A 54 GlgE 54 clinically detectable 54 Squalamine 54 detecting coronary artery 54 vitamin D receptors 54 amyloid toxicity 54 metastatic renal 53 Joan Massagué 53 HG PIN 53 Basal cell 53 papillary renal cell carcinoma 53 thetreatment 53 radiosensitivity 53 atherogenesis 53 SOCS2 53 esophagogastric junction 53 lymphoid cells 53 anti angiogenic drugs 53 pathophysiological mechanisms 53 preclinically 53 proteomic analysis 53 directly degrades fibrin 53 Id1 53 gastric cardia 53 ixabepilone 53 Randomized clinical trials 53 DNA methylation biomarkers 53 abnormal p# 53 neuromuscular junction 53 dedifferentiation 53 N. gonorrhoeae 53 AE# vaccine 53 treating cancerous tumors 53 breast cancer subtypes 53 tumorigenicity 53 urokinase plasminogen activator 53 diabetic kidney 53 Septin9 53 ductal adenocarcinoma 53 Sentinel node biopsy 53 TGF ß1 53 aP2 53 kinase pathway 53 precancerous condition 53 transgene expression 53 chronic thromboembolic pulmonary 53 chromosomal rearrangement 53 node metastases 53 Leydig cell 53 thrombo embolic 53 esophagogastric 53 basal epithelial 53 TP# mutation 53 neuropilin 53 skin sparing mastectomy 53 KLF4 53 peptide antigens 53 preoperative staging 53 neurotrophic 53 apoptosis induced 53 Dr. Rafii 53 melanocyte 53 Cyclin D1 53 NF kB pathway 53 molecular underpinnings 53 amyloid formation 53 serine protease 53 GRNCM1 53 Bcl xL 53 USP# 53 susceptibility loci 53 IntroductionThe 53 chitinase 53 CB2 receptor 53 precancerous colon growths 53 p# MAPK 53 colonic polyps 53 diagnostic modality 53 predictive biomarkers 53 fluorescence endoscopy 53 nonhereditary 53 proteomic biomarkers 53 situ LCIS 53 NGAL 53 cytolytic 53 benign ovarian 53 CpG island 53 Fc receptor 53 microsatellite instability 53 small molecule agonists 53 mitochondrial fusion 53 iPSC 53 Adjuvant chemotherapy 53 leukaemic cells 53 5 hydroxymethylcytosine 53 genomic biomarker 53 lung pancreatic 53 adjuvant therapies 53 hypoxic tumors 53 potent inhibitors 53 TNF blocker therapy 53 distant metastasis 53 biologic plausibility 53 neovascularization 53 molecularly targeted therapies 53 cellular pathways 53 Hsp# inhibition 53 HepDirect prodrug 53 lymph node metastasis 53 p#/CBP 53 ARRY # 53 inhibiting mTOR 53 Jhdm2a 53 sphingolipids 53 ADPKD 53 hepatic lipase 53 TBNA 53 Dr. Victor Velculescu 53 matriptase 53 AGTR1 53 virulence genes 53 molecular etiology 53 gastric carcinomas 53 Dr. Karsenty 53 oncogenic transformation 53 CEACAM1 53 KRAS mutant 53 HLA DQ2 53 whose tumors overexpress 53 sarcomatoid 53 adipose derived regenerative 53 castration resistant hormone refractory 53 vivo validation 53 cytoreduction 53 Immunosuppressive drugs 53 renal carcinoma 53 SELDI TOF MS 53 regenerative therapy 53 immunoregulation 53 LaBaer 53 bronchial epithelial cells 53 thymic carcinoma 53 nonmetastatic 53 TGF β 53 adult neurogenesis 53 HSF1 53 LHRH receptor positive 53 JAK3 53 HER2 positivity 53 interferon beta therapy 53 MSH2 53 transcriptional activation 53 UVB induced 53 proteoglycan 53 prostate cancer CaP 53 hESC derived cardiomyocytes 53 NOD mouse 53 RNA splicing 53 thyroid carcinomas 53 lung epithelium 53 inhibiting tumor 53 #F FDG PET 53 HER2 expression 53 invasive lobular 53 etiologic agent 53 Dr. Fehlings 53 EUS FNA 53 ovarian uterine 53 sonographic diagnosis 53 cholesterol metabolism 53 Genetic variations 53 adenomatous 53 FTIs 53 Prognostic factors 52 somatostatin receptor 52 cervical carcinoma 52 leukemia multiple myeloma 52 cellular microenvironment 52 antitumor effect 52 Hutchinson Gilford progeria 52 pancreatic islet cell 52 VEGF inhibition 52 CALHM1 52 neoplastic cells 52 microRNA profiling 52 endocrine therapies 52 urothelial carcinoma 52 immunotherapeutic vaccine 52 malignant ascites 52 pulmonary inflammation 52 engineered RAP peptides 52 SPORE grant 52 Kenneth Kinzler 52 cardiac fibrosis 52 antisense oligonucleotides 52 pancreatic ovarian 52 nasopharyngeal carcinoma 52 Curaxin 52 surgically resectable 52 mutant p# 52 cholesterol biosynthesis 52 ovarian colon 52 urothelial 52 epigenetic mechanisms 52 gene locus 52 CaM kinase 52 neovasculature 52 sentinel lymph node biopsy 52 osteoblastic 52 Lung transplantation 52 Treg cell 52 intracellular pathway 52 tenascin 52 transdifferentiation 52 PMR1 52 Genetic mutation 52 prognostic significance 52 microRNA biomarkers 52 vascular inflammation 52 delipidation 52 DNA demethylation 52 intra arterial chemotherapy 52 Skeletal muscle 52 GeneICE 52 Androgen deprivation therapy 52 HepaMate ™ 52 thyroid carcinoma 52 dissolving clots 52 StemEx R 52 gastric adenocarcinoma 52 BMP4 52 OxBC 52 miRview TM mets 52 CYT# potent vascular disrupting 52 DCVax 52 metastatic prostate 52 histologic subtype 52 nonalcoholic steatohepatitis NASH 52 ADVEXIN therapy 52 Chronic lymphocytic leukemia CLL 52 pulmonary metastases 52 infectious prion proteins 52 ras oncogene 52 parthenogenetic stem cells 52 histone deacetylase 52 LRP1 52 benign prostatic hyperplasia enlarged 52 perineural invasion 52 HDAC3 52 tested eribulin 52 signaling cascades 52 immuno modulatory 52 Genetic variation 52 osteoclast 52 effector protein 52 nanobacteria 52 extracapsular 52 lymphatic vessel 52 immatics 52 Brd4 52 parthenolide 52 inducible nitric oxide synthase 52 resolvins 52 Elevated CRP 52 HGPIN 52 siRNA knockdown 52 bladder tumors 52 cardiac troponin 52 serine proteases 52 siRNA therapeutics 52 theranostic 52 bisulfite sequencing 52 Bryostatin 52 tryptase 52 lesional 52 micro RNA 52 PKC alpha 52 Microarray analysis 52 cathepsin K 52 precancerous tumors 52 malignant ovarian 52 protein homeostasis 52 Debinski 52 Wnt pathway 52 immunoregulatory 52 ovarian carcinoma 52 intracellular protein 52 colorectal ovarian 52 multivessel coronary artery 52 nonsmall cell lung cancer 52 hormone refractory 52 Oncimmune 52 neovascularisation 52 Dr. Kolls 52 ImmuKnow 52 stem cell differentiation 52 secretes insulin 52 Getzenberg 52 DLX5 52 treating neuropathic pain 52 OHR/AVR# 52 lactate dehydrogenase LDH 52 rhabdoid 52 CENP E 52 lipid synthesis 52 promyelocytic leukemia 52 intracellular signaling pathways 52 atypical lobular hyperplasia 52 genetic polymorphisms 52 bavituximab monotherapy trial 52 untreated metastatic melanoma 52 serum biomarker 52 epithelioid 52 Caloric restriction 52 bacterial enzyme 52 Hepatocellular Carcinoma HCC 52 uterine ovarian 52 TRUS biopsy 52 synovial cells 52 peptide therapeutics 52 pathophysiologic mechanism 52 colorectum 52 apelin 51 EGFR HER 51 mass spectrometric 51 VEGF receptor 51 humanized mouse 51 anoikis 51 biomarker 51 Squamous cell 51 mesenchymal stromal cells 51 motor neuron diseases 51 endometrial kidney 51 NRG1 51 BRAF mutant 51 resectable 51 transcriptional profiling 51 Endothelial dysfunction 51 lobular carcinoma 51 vascular thrombosis 51 KRAS mutation status 51 SIR Spheres 51 intercellular communication 51 plexiform 51 biochemical abnormalities 51 myocardial ischaemia 51 Hotamisligil 51 HNSCC 51 histone modifications 51 muscular dystrophies 51 autologous transplants 51 cardiotoxic effects 51 CMV vaccine 51 Neogenix 51 alpha7 51 Litx 51 aneuploid 51 GPR# [002] 51 Th2 responses 51 Iruela Arispe 51 MGd 51 vascular disrupting agents 51 synaptic function 51 PET tracers 51 previously uncharacterized 51 growth factor CTGF 51 EGFR mutation status 51 HER2 positive cancers 51 tumor vascularization 51 Wnt proteins 51 chromosomal mutations 51 RNAi therapeutic targeting 51 metastasis 51 bladder augmentation 51 axillary lymph nodes 51 ovarian lung 51 neurotransmitter receptor 51 noncoding RNA 51 biomarkers 51 colorectal bladder 51 epigenomic 51 lymph node metastases 51 diagnose Alzheimer disease 51 serologic tests 51 mitochondrial disorders 51 Lymphocytic 51 tumoral 51 survivin expression 51 PDE7B 51 hypercoagulable 51 antioxidant enzymes 51 autoantigens 51 nonmelanoma 51 TGF beta1 51 Computed tomography 51 allogeneic HSCT 51 synapse formation 51 eTag assays 51 aberrant methylation 51 leukemia lymphomas 51 EGFR expression 51 proximal colon 51 deCODE AF TM 51 gemcitabine chemotherapy 51 neurodegenerative illnesses 51 Prenatal diagnosis 51 radiochemotherapy 51 theranostics 51 thromboembolic disease 51 antioxidant supplementation 51 Dr. Ruoslahti 51 axillary node 51 Skordalakes 51 vitro assay 51 hormonally responsive 51 chimeric protein 51 pelvic malignancies 51 idiopathic pulmonary 51 Trophos 51 Kaklamani 51 gastro intestinal inflammation 51 leukotriene pathway 51 premalignant lesion 51 K ras gene 51 humoral immunity 51 biodegradable nanoparticles 51 situ hybridization ISH 51 hypervascular tumors 51 nephrogenic 51 Notch pathway 51 TTR amyloidosis 51 carcinoid 51 quantitative proteomics 51 multiorgan 51 molecular diagnostic assays 51 BioScanIR R System 51 obstructive coronary 51 P#X# 51 medically inoperable 51 HDAC inhibition 51 invasive carcinoma 51 immunosuppressive regimens 51 colorectal tumor 51 LungAlert TM 51 bronchial inflammation 51 malignant brain 51 prophylactic cranial irradiation 51 atopic march 51 collagen VI 51 T1a 51 chromosome #p# [002] 51 therapeutically useful 51 Prostate specific antigen 51 FDG PET imaging 51 Nurr1 51 molecular diagnostic assay 51 carcinoid tumors 51 MAP kinase pathway 51 S. maltophilia 51 metaplasia 51 adhesion molecule EpCAM expressing 51 liver scarring 51 paraneoplastic 51 cranial irradiation 51 clonal expansion 51 etiologic 51 protein misfolding 51 Vascugel R 51 refractory colorectal cancer 51 trophic factors 51 intraductal 51 CCR9 antagonist 51 neurite outgrowth 51 therapeutic modality 51 MMP9 51 Mechanistic studies 51 intracellular signaling pathway 51 cellular reprogramming 51 MCF7 51 bony metastases 51 inhibiting enzymes 51 nicotinic acetylcholine receptors 51 novel therapeutic antibodies 51 sGC 51 telomerase enzyme 51 tissue microarray 51 coagulation disorders 51 Radical prostatectomy 51 ferroportin levels 51 riociguat 51 HHV 6 51 antibody reagents 51 validating biomarkers 51 Pin1 51 p# deficient 51 intimal hyperplasia 51 leukemic stem cells 51 squamous carcinoma 51 neoadjuvant therapy 51 prostate colon 51 Hurthle cell 51 acidic reflux 51 Fc receptors 51 5 HT2A serotonin 51 prolongs survival 51 molecular pathways 51 prognostically 51 genomic profiling 51 enzyme NADPH oxidase 51 cardiometabolic disorders 51 EGF receptors 51 pilocytic astrocytomas 51 T SPOT.TB 51 LRRK2 mutations 51 tumor histology 51 miR# 51 hepatocellular carcinoma liver 51 damage cirrhosis liver 51 Dr. Ivashkiv 51 demonstrated antitumor activity 51 epigenetic silencing 51 Therapeutic antibodies 50 adaptive immunity 50 anti inflammatory cytokine 50 neural degeneration 50 leiomyomas 50 Kohwi Shigematsu 50 premalignant lesions 50 molecular profiling 50 molecular pathway 50 MTT assay 50 localized prostate 50 gene expression microarray 50 CVD cardiovascular disease 50 Epstein Barr Virus EBV 50 PLAC test 50 gastroesophageal 50 submandibular gland 50 branching morphogenesis 50 lipid nanoparticle LNP 50 miRagen 50 micrometastasis 50 Htt 50 axon regeneration 50 biomarker assay 50 interleukin IL -# 50 fibrotic disease 50 recombinant plasma 50 tissue homeostasis 50 curative resection 50 myeloproliferative disorders 50 multimodality imaging 50 buccal delivery 50 BEXXAR Therapeutic Regimen 50 polycythemia vera PV 50 commented Geert Nygaard 50 benign neoplasms 50 anti angiogenic agents 50 childhood acute lymphoblastic 50 resistant hormone refractory 50 2DG 50 BCL6 gene 50 metachronous 50 novel peptide therapeutics 50 localized renal 50 thyroid peroxidase 50 mtDNA mutations 50 ligases 50 TOP2A gene 50 HepaLife 50 adrenocortical cancer 50 ependymomas 50 neurexins 50 Mdm2 50 immunopathology 50 investigational therapies 50 sirtuin inhibitors 50 neurofibromas 50 depsipeptide 50 premalignant 50 invasive ductal 50 locoregional recurrence 50 YONDELIS 50 Gnant consults 50 aerosolized KL4 surfactant 50 ANCA associated 50 syngeneic 50 KRAS mutations 50 vascularisation 50 JAK inhibitors 50 endometrial ovarian 50 monoclonal gammopathy 50 angiographically 50 androgen ablation 50 pericytes 50 embryonal rhabdomyosarcoma 50 Monoclonal antibody 50 retroviral infection